{
    "qwen-v2.5-14b-instruct": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "qwen-v2.5-14b-instruct",
            "response": [
                "Tamoxifen (TAM)",
                "Anastrozole (ANA)",
                "Letrozole (LET)",
                "Exemestane (EXE)",
                "Ovarian ablation",
                "Palbociclib (PAL)",
                "Ibrance",
                "Fulvestrant (FUL)",
                "Afinitor (Everolimus)",
                "Neratinib (NIRA)",
                "Toremifene (TOR)",
                "Abemaciclib (ABE)",
                "Lynparza (Olaparib)",
                "Kisqali (Ribociclib)",
                "Ixabepilone (IXA)",
                "T-DM1 (Trastuzumab emtansine)",
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Alpelisib (ALP)",
                "Everolimus (RAD001)",
                "Lumacaftor (LUM)",
                "Sacituzumab govitecan (SG)",
                "Enhertu (Fam-trastuzumab deruxtecan-nxki)"
            ]
        }
    ],
    "phi-v4": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "phi-v4",
            "response": [
                "Anastrozole (Arimidex)",
                "Bicalutamide (Casodex)",
                "Bisphosphonates (e.g., Zoledronic acid, Zometa)",
                "Cabazitaxel (Jevtana)",
                "Cyclophosphamide (Cytoxan)",
                "Doxorubicin (Adriamycin)",
                "Eribulin (Halaven)",
                "Fluorouracil (5-FU)",
                "Goserelin (Zoladex)",
                "Ixabepilone (Ixempra)",
                "Letrozole (Femara)",
                "Leuprolide (Lupron)",
                "Megestrol acetate (Megace)",
                "Methotrexate (Trexall)",
                "Mitomycin C (Mutamycin)",
                "Paclitaxel (Taxol)",
                "Tamoxifen (Nolvadex)",
                "Trastuzumab (Herceptin)",
                "Vandetanib (Caprelsa)",
                "Vinorelbine (Navelbine)",
                "Exemestane (Aromasin)",
                "Everolimus (Afinitor)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)"
            ]
        }
    ],
    "mistral-small-instruct-24B": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "mistral-small-instruct-24B",
            "response": [
                "Tamoxifen (Nolvadex)",
                "Anastrozole (Arimidex)",
                "Letrozole (Femara)",
                "Exemestane (Aromasin)",
                "Fulvestrant (Faslodex)",
                "Raloxifene (Evista)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Olaparib (Lynparza)",
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Lapatinib (Tykerb)",
                "Everolimus (Afinitor)",
                "T-DM1 (Ado-trastuzumab emtansine, Kadcyla)",
                "Neratinib (Nerlynx)",
                "Capivasertib",
                "Buparlisib",
                "Alpelisib",
                "Tucatinib (Tukysa)",
                "Sacituzumab govitecan (Trodelvy)",
                "Sacituzumab govitecan (Trodelvy)",
                "Enzalutamide (Xtandi)"
            ]
        }
    ],
    "gemma-3": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "gemma-3",
            "response": [
                "Tamoxifen (TAM)",
                "Raloxifene (RAL)",
                "Letrozole (LET)",
                "Anastrozole (ANA)",
                "Exemestane (EXE)",
                "Fulvestrant (FUL)",
                "Palbociclib (PAL)",
                "Ribociclib (RIB)",
                "Abemaciclib (ABE)",
                "Trastuzumab (HER)",
                "Pertuzumab (PER)",
                "Ado-trastuzumab emtansine (T-DM1)",
                "Sacituzumab govitecan (SG)",
                "Olaparib (OLA)",
                "Talazoparib (TAL)",
                "Capecitabine (CAP)",
                "Cyclophosphamide (CYC)",
                "Doxorubicin (DOX)",
                "Paclitaxel (PAC)",
                "Docetaxel (DOC)",
                "Vinorelbine (VIN)",
                "5-Fluorouracil (5-FU)",
                "Gemcitabine (GEM)",
                "Tucatinib (TUC)"
            ]
        }
    ],
    "gpt-4o": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "gpt-4o",
            "response": [
                "Tamoxifen (Nolvadex)",
                "Anastrozole (Arimidex)",
                "Letrozole (Femara)",
                "Exemestane (Aromasin)",
                "Fulvestrant (Faslodex)",
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Everolimus (Afinitor)",
                "Lapatinib (Tykerb)",
                "Neratinib (Nerlynx)",
                "Olaparib (Lynparza)",
                "Talazoparib (Talzenna)",
                "Alpelisib (Piqray)",
                "Capecitabine (Xeloda)",
                "Vinorelbine (Navelbine)",
                "Docetaxel (Taxotere)",
                "Paclitaxel (Taxol)",
                "Cyclophosphamide (Cytoxan)",
                "Doxorubicin (Adriamycin)",
                "Carboplatin",
                "Fluorouracil (5-FU)"
            ]
        }
    ],
    "gpt-4o-mini": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "gpt-4o-mini",
            "response": [
                "Tamoxifen (TAM)",
                "Anastrozole (ANA)",
                "Letrozole (LET)",
                "Exemestane (EXE)",
                "Trastuzumab (HER2)",
                "Pertuzumab (PER)",
                "Lapatinib (LAP)",
                "Palbociclib (PAL)",
                "Ribociclib (RIB)",
                "Abemaciclib (ABE)",
                "Fulvestrant (FUL)",
                "Capecitabine (CAP)",
                "Docetaxel (DOC)",
                "Doxorubicin (DOX)",
                "Cyclophosphamide (CYC)",
                "Tamoxifen Citrate (TAM-C)",
                "Aromasin (ARO)",
                "Zoladex (GOS)",
                "Neratinib (NER)",
                "Adjuvant Chemotherapy (AC)",
                "Everolimus (EVE)",
                "Tucatinib (TUC)",
                "Olaparib (OLA)",
                "Sacituzumab Govitecan (SG)",
                "Bicalutamide (BIC)"
            ]
        }
    ],
    "gpt-4-32k": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "gpt-4-32k",
            "response": [
                "Tamoxifen (Nolvadex)",
                "Fulvestrant (Faslodex)",
                "Anastrozole (Arimidex)",
                "Letrozole (Femara)",
                "Exemestane (Aromasin)",
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Ado-trastuzumab emtansine (Kadcyla)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Lapatinib (Tykerb)",
                "Neratinib (Nerlynx)",
                "Everolimus (Afinitor)",
                "Toremifene (Fareston)",
                "Raloxifene (Evista)",
                "Olaparib (Lynparza)",
                "Talazoparib (Talzenna)",
                "Capecitabine (Xeloda)",
                "Paclitaxel (Taxol)",
                "Docetaxel (Taxotere)",
                "Carboplatin (Paraplatin)",
                "Epirubicin (Ellence)",
                "Cyclophosphamide (Cytoxan)"
            ]
        }
    ],
    "gpt-35-turbo-16k": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "gpt-35-turbo-16k",
            "response": [
                "Tamoxifen",
                "Letrozole",
                "Anastrozole",
                "Exemestane",
                "Fulvestrant",
                "Arimidex",
                "Aromasin",
                "Fareston",
                "Nolvadex",
                "Evista",
                "Afinitor",
                "Ibrance",
                "Kisqali",
                "Verzenio",
                "Perjeta",
                "Herceptin",
                "Tykerb",
                "Kadcyla",
                "Halaven",
                "Abraxane",
                "Xeloda",
                "Taxol",
                "Adriamycin",
                "Cytoxan"
            ]
        }
    ],
    "o1-mini": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "o1-mini",
            "response": [
                "Tamoxifen (Nolvadex)",
                "Anastrozole (Arimidex)",
                "Letrozole (Femara)",
                "Exemestane (Aromasin)",
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Paclitaxel (Taxol)",
                "Docetaxel (Taxotere)",
                "Fulvestrant (Faslodex)",
                "Ribociclib (Kisqali)",
                "Palbociclib (Ibrance)",
                "Abemaciclib (Verzenio)",
                "Everolimus (Afinitor)",
                "Alpelisib (Piqray)",
                "Neratinib (Nerlynx)",
                "Olaparib (Lynparza)",
                "Trastuzumab emtansine (Kadcyla)",
                "Vinorelbine (Navelbine)",
                "Cyclophosphamide (Cytoxan)",
                "Methotrexate (Trexall)",
                "Carboplatin (Paraplatin)",
                "Bevacizumab (Avastin)",
                "Ixabepilone (Ixempra)",
                "Sacituzumab govitecan (Trodelvy)"
            ]
        }
    ],
    "anthropic.claude-3-5-sonnet-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "anthropic.claude-3-5-sonnet-v1:0",
            "response": [
                "Tamoxifen (TAM)",
                "Anastrozole (ANA)",
                "Letrozole (LET)",
                "Exemestane (EXE)",
                "Fulvestrant (FUL)",
                "Raloxifene (RAL)",
                "Goserelin (GOS)",
                "Leuprolide (LEU)",
                "Triptorelin (TRI)",
                "Palbociclib (PAL)",
                "Ribociclib (RIB)",
                "Abemaciclib (ABE)",
                "Olaparib (OLA)",
                "Talazoparib (TAL)",
                "Neratinib (NER)",
                "Pertuzumab (PER)",
                "Trastuzumab (TRA)",
                "Ado-trastuzumab emtansine (T-DM1)",
                "Lapatinib (LAP)",
                "Everolimus (EVE)",
                "Alpelisib (ALP)",
                "Tucatinib (TUC)",
                "Sacituzumab govitecan (SAC)",
                "Fam-trastuzumab deruxtecan-nxki (T-DXd)"
            ]
        }
    ],
    "anthropic.claude-3-opus-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "anthropic.claude-3-opus-v1:0",
            "response": [
                "Tamoxifen",
                "Raloxifene",
                "Anastrozole (Arimidex)",
                "Exemestane (Aromasin)",
                "Letrozole (Femara)",
                "Fulvestrant (Faslodex)",
                "Everolimus (Afinitor)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Abemaciclib (Verzenio)",
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Ado-trastuzumab emtansine (Kadcyla)",
                "Lapatinib (Tykerb)",
                "Neratinib (Nerlynx)",
                "Olaparib (Lynparza)",
                "Talazoparib (Talzenna)",
                "Alpelisib (Piqray)",
                "Tucatinib (Tukysa)",
                "Margetuximab (Margenza)",
                "Sacituzumab govitecan (Trodelvy)",
                "Fam-trastuzumab deruxtecan (Enhertu)",
                "Capecitabine (Xeloda)",
                "Paclitaxel"
            ]
        }
    ],
    "anthropic.claude-3-sonnet-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "anthropic.claude-3-sonnet-v1:0",
            "response": [
                "tamoxifen (TAM)",
                "raloxifene (RAL)",
                "anastrozole (ANA)",
                "exemestane (EXE)",
                "letrozole (LET)",
                "palbociclib (PAL)",
                "ribociclib (RIB)",
                "abemaciclib (ABE)",
                "everolimus (EVE)",
                "alpelisib (ALP)",
                "trastuzumab (TRA)",
                "pertuzumab (PER)",
                "lapatinib (LAP)",
                "neratinib (NER)",
                "tucatinib (TUC)",
                "olaparib (OLA)",
                "talazoparib (TAL)",
                "goserelin (GOS)",
                "leuprolide (LEU)",
                "fulvestrant (FUL)",
                "capecitabine (CAP)",
                "gemcitabine (GEM)",
                "doxorubicin (DOX)",
                "paclitaxel (PAC)"
            ]
        }
    ],
    "anthropic.claude-3-haiku-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "anthropic.claude-3-haiku-v1:0",
            "response": [
                "Tamoxifen (TAM)",
                "Fulvestrant (FUL)",
                "Letrozole (LET)",
                "Anastrozole (ANA)",
                "Exemestane (EXE)",
                "Palbociclib (PAL)",
                "Ribociclib (RIB)",
                "Abemaciclib (ABE)",
                "Trastuzumab (TRA)",
                "Pertuzumab (PER)",
                "Lapatinib (LAP)",
                "Neratinib (NER)",
                "Ado-trastuzumab emtansine (T-DM1)",
                "Olaparib (OLA)",
                "Talazoparib (TAL)",
                "Alpelisib (ALP)",
                "Everolimus (EVE)",
                "Ribociclib + Letrozole (RIB+LET)",
                "Palbociclib + Letrozole (PAL+LET)",
                "Abemaciclib + Fulvestrant (ABE+FUL)",
                "Trastuzumab + Pertuzumab (TRA+PER)",
                "Trastuzumab + Emtansine (T-DM1)",
                "Olaparib + Paclitaxel (OLA+PAC)",
                "Alpelisib + Fulvestrant (ALP+FUL)"
            ]
        }
    ],
    "meta.llama3-8b-instruct-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "meta.llama3-8b-instruct-v1:0",
            "response": [
                "Tamoxifen (Tamoxifen)",
                "Raloxifene (Raloxifene)",
                "Fulvestrant (Fulvestrant)",
                "Exemestane (Exemestane)",
                "Letrozole (Letrozole)",
                "Anastrozole (Anastrozole)",
                "Aromasin (Exemestane)",
                "Arimidex (Anastrozole)",
                "Faslodex (Fulvestrant)",
                "Evista (Raloxifene)",
                "Aromasin (Exemestane)",
                "Femara (Letrozole)",
                "Nolvadex (Tamoxifen)",
                "Soltamox (Tamoxifen)",
                "Tamoxifen Citrate (Tamoxifen)",
                "Aromasin (Exemestane)",
                "Faslodex (Fulvestrant)",
                "Arimidex (Anastrozole)",
                "Evista (Raloxifene)",
                "Femara (Letrozole)",
                "Nolvadex (Tamoxifen)",
                "Soltamox (Tamoxifen)",
                "Tamoxifen Citrate (Tamoxifen)",
                "Fulvestrant (Fulvestrant)",
                "Exemestane (Exemestane)",
                "Letrozole (Letrozole)",
                "Anastrozole (Anastrozole)"
            ]
        }
    ],
    "meta.llama3-70b-instruct-v1:0": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "meta.llama3-70b-instruct-v1:0",
            "response": [
                "Tamoxifen (Soltamox)",
                "Raloxifene (Evista)",
                "Toremifene (Fareston)",
                "Anastrozole (Arimidex)",
                "Letrozole (Femara)",
                "Exemestane (Aromasin)",
                "Fulvestrant (Faslodex)",
                "Abemaciclib (Verzenio)",
                "Palbociclib (Ibrance)",
                "Ribociclib (Kisqali)",
                "Everolimus (Afinitor)",
                "Trastuzumab (Herceptin)",
                "Pertuzumab (Perjeta)",
                "Ado-trastuzumab emtansine (Kadcyla)",
                "Neratinib (Nerlynx)",
                "Lapatinib (Tykerb)",
                "Capecitabine (Xeloda)",
                "Docetaxel (Taxotere)",
                "Paclitaxel (Taxol)",
                "Eribulin (Halaven)",
                "Vinorelbine (Navelbine)",
                "Cyclophosphamide (Cytoxan)",
                "Doxorubicin (Adriamycin)"
            ]
        }
    ],
    "amazon.titan-text-express-v1": [
        {
            "call": "limited-list-referents-from-selection-criteria",
            "context": {
                "selection_criteria": "[\"it is a drug\", \"it has been approved to prevent or treat breast cancer\"]",
                "n": "24",
                "domain": "medicine",
                "concept": "approved drug for breast cancer"
            },
            "model": "amazon.titan-text-express-v1",
            "response": [
                {
                    "referent": "tamoxifen",
                    "canonical name": "tamoxifen"
                },
                {
                    "referent": "exemestane",
                    "canonical name": "exemestane"
                },
                {
                    "referent": "letrozole",
                    "canonical name": "letrozole"
                },
                {
                    "referent": "anastrozole",
                    "canonical name": "anastrozole"
                },
                {
                    "referent": "fulvestrant",
                    "canonical name": "fulvestrant"
                }
            ]
        }
    ]
}